AbbVie Inc. (BCBA:ABBV)
Argentina
· Delayed Price · Currency is ARS 21,775
-200 (-0.91%)
May 13, 2025, 5:00 PM BRT
Revenue by Product
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Immunology | 27.58B |
Log In |
Log In |
Log In |
Log In |
| Immunology Growth | 6.39% |
Log In |
Log In |
Log In |
Log In |
| Oncology | 6.65B |
Log In |
Log In |
Log In |
Log In |
| Oncology Growth | 9.98% |
Log In |
Log In |
Log In |
Log In |
| Other Key Products | 3.56B |
Log In |
Log In |
Log In |
Log In |
| Other Key Products Growth | -5.85% |
Log In |
Log In |
Log In |
Log In |
| All Other | 3.04B |
Log In |
Log In |
Log In |
Log In |
| All Other Growth | -1.72% |
Log In |
Log In |
Log In |
Log In |
| Neuroscience | 9.32B |
Log In |
Log In |
Log In |
Log In |
| Neuroscience Growth | 16.64% |
Log In |
Log In |
Log In |
Log In |
| Women's Health | - |
Log In |
Log In |
Log In |
Log In |
| Women's Health Growth | - |
Log In |
Log In |
Log In |
Log In |
| Aesthetics | 5.03B |
Log In |
Log In |
Log In |
Log In |
| Aesthetics Growth | -4.08% |
Log In |
Log In |
Log In |
Log In |
| Eye Care | 2.21B |
Log In |
Log In |
Log In |
Log In |
| Eye Care Growth | -5.76% |
Log In |
Log In |
Log In |
Log In |
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| United States | 43.97B |
Log In |
Log In |
Log In |
Log In |
| United States Growth | 5.38% |
Log In |
Log In |
Log In |
Log In |
| International | 13.40B |
Log In |
Log In |
Log In |
Log In |
| International Growth | 5.68% |
Log In |
Log In |
Log In |
Log In |